This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Jubilant Biosys Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Vellarkad Narayana Viswanadhan: Innovator in Medicinal Chemistry
Introduction
Vellarkad Narayana Viswanadhan is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrimidine compounds. His research focuses on the development of compounds that have potential therapeutic applications.
Latest Patents
Vellarkad Narayana Viswanadhan holds a patent for "Substituted pyrimidine compounds, compositions and medicinal applications thereof." This patent relates to pyrimidine compounds of a specific formula, including their stereoisomers, tautomers, pharmaceutically acceptable salts, polymorphs, solvates, and hydrates. The disclosure also covers the process of preparing these compounds and pharmaceutical compositions containing them. These compounds are particularly useful in treating, preventing, or suppressing diseases and disorders mediated by epidermal growth factor receptor (EGFR) family kinases. He has 1 patent to his name.
Career Highlights
Vellarkad Narayana Viswanadhan is currently associated with Jubilant Biosys Limited, where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential impact on drug development and therapeutic interventions.
Collaborations
Some of his notable coworkers include Chandregowda Venkateshappa and Dhanalakshmi Sivanandhan, who contribute to the collaborative efforts in their research projects.
Conclusion
Vellarkad Narayana Viswanadhan's innovative work in the field of medicinal chemistry exemplifies the importance of research in developing new therapeutic agents. His contributions, particularly in the area of pyrimidine compounds, highlight the potential for advancements in treating various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile